Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 984.29M | 660.01M | 1.04B | 1.24B | 1.34B |
Gross Profit | 36.33M | 4.28M | 37.75M | 54.96M | 30.27M |
EBITDA | 115.19M | -75.18M | -29.10M | -35.65M | -79.91M |
Net Income | 109.16M | 40.72M | 231.02M | 269.79M | 93.44M |
Balance Sheet | |||||
Total Assets | 1.87B | 1.75B | 1.75B | 1.59B | 1.39B |
Cash, Cash Equivalents and Short-Term Investments | 80.85M | 133.32M | 180.61M | 172.48M | 167.59M |
Total Debt | 36.24M | 20.10M | 7.62M | 1.65M | 104.52M |
Total Liabilities | 162.61M | 140.25M | 123.43M | 161.61M | 212.82M |
Stockholders Equity | 1.71B | 1.60B | 1.61B | 1.41B | 1.17B |
Cash Flow | |||||
Free Cash Flow | -34.61M | -16.27M | 45.93M | 159.42M | -11.15M |
Operating Cash Flow | -33.88M | -6.71M | 46.70M | 159.61M | -5.97M |
Investing Cash Flow | -14.81M | 10.76M | -20.74M | -2.25M | -21.24M |
Financing Cash Flow | 4.50M | -33.54M | -30.88M | -137.04M | 10.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $87.49B | 12.93 | 18.17% | 8.59% | 12.76% | 34.50% | |
72 Outperform | HK$82.69B | 28.43 | 11.45% | 0.70% | 18.80% | 142.93% | |
71 Outperform | HK$363.47M | 6.77 | 3.12% | 10.00% | 77.75% | 295.97% | |
59 Neutral | $8.95B | ― | -1.35% | ― | -11.86% | 83.13% | |
56 Neutral | HK$25.30B | 3.94 | -2.03% | 6.16% | -0.31% | -67.70% | |
47 Neutral | $619.21M | ― | -8.33% | ― | -9.43% | 2.47% | |
44 Neutral | HK$177.41M | ― | -19.24% | ― | -10.08% | -417.56% |